Comparison of Two Different Intensity Exercises on Young Women With Obesity

NCT06610955 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-02-05

No results posted yet for this study

Summary

Obesity is one of the most common preventable public health problems. Diet regulation and exercise practices are the most commonly used methods in reducing fat tissue. There are various exercise methods applied in the weight loss process and the effects of different types of exercise modalities on body fat rate and metabolic status.The aim of our study is to determine the effects of high intensity interval exercise and moderate intensity continuous exercise on serum , omentin, leptin and adiponectin levels, anthropometric measurements used in obesity follow up, body fat percentage and their effects on the quality of sleep and life of women with obesity.

Conditions

Interventions

OTHER

High intensity interval training

After a 10 minutes warm up exercise, participants will exercise with a bicycle ergometry device at 80% of their maximum heart rate for 4 minutes, and the active recovery period will be 3 minutes (4x4 minutes). During the recovery period, the participant will exercise with the Ergoline bicycle ergometry system for 4 sets at 60% of their maximum heart rate for 3 minutes. A total of 45 minutes exercise session will be completed with a 10 minutes cool down exercise. Exercise will be done 5 days a week for a total of 8 weeks. In the first 4 weeks, exercise will be done at 80% intensity, and in the following weeks, the exercise intensity will be increased by 5% each week, respectively, to 85%, 90%, 95%, and 100% in the last week.

OTHER

Moderate intensity continuous training

Following a 10 minutes warm up exercise, participants will exercise continuously for 30 minutes at 65% of their maximum heart rate with the Ergoline bicycle ergometry system. A 5 minutes cool down exercise will end the 45 minutes exercise session. The exercise duration is 5 days a week for a total of 8 weeks.

Sponsors & Collaborators

  • Kirsehir Ahi Evran Universitesi

    collaborator OTHER
  • Ahi Evran University Education and Research Hospital

    lead OTHER

Principal Investigators

  • Figen Tuncay, Professor · Ahi Evran Univeristy

  • Elif Kapaklı, RA · Kirsehir Ahi Evran Universitesi

  • Gamze Turna Saltoğlu, Ass. Prof. · Kirsehir Ahi Evran Universitesi

  • Başak Çiğdem Karaçay, Assoc. Prof. · Kirsehir Ahi Evran Universitesi

  • Nazife Kapan, Ass. Prof. · Kirsehir Ahi Evran Universitesi

  • Başak Kavalcı Kol, Ass. Prof. · Kirsehir Ahi Evran Universitesi

  • Merve Fırat, Ass. Prof. · Kirsehir Ahi Evran Universitesi

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-18
Primary Completion
2025-07-31
Completion
2025-07-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06610955 on ClinicalTrials.gov